These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11061544

  • 1. Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells.
    Gründker C, Schulz K, Günthert AR, Emons G.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3815-20. PubMed ID: 11061544
    [Abstract] [Full Text] [Related]

  • 2. Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells.
    Günthert AR, Gründker C, Böttcher B, Emons G.
    Anticancer Res; 2004 Oct; 24(3a):1727-32. PubMed ID: 15274347
    [Abstract] [Full Text] [Related]

  • 3. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
    Günthert AR, Gründker C, Hollmann K, Emons G.
    Biochem Biophys Res Commun; 2002 May 31; 294(1):11-5. PubMed ID: 12054733
    [Abstract] [Full Text] [Related]

  • 4. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C, Völker P, Emons G.
    Endocrinology; 2001 Jun 31; 142(6):2369-80. PubMed ID: 11356684
    [Abstract] [Full Text] [Related]

  • 5. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C, Völker P, Schulz KD, Emons G.
    Gynecol Oncol; 2000 Aug 31; 78(2):194-202. PubMed ID: 10926802
    [Abstract] [Full Text] [Related]

  • 6. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct 31; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 7. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S, Schlotawa L, Günthert AR, Emons G, Gründker C.
    Gynecol Endocrinol; 2008 Jan 31; 24(1):24-9. PubMed ID: 17943530
    [Abstract] [Full Text] [Related]

  • 8. Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin.
    Gründker C, Schlotawa L, Viereck V, Emons G.
    Eur J Endocrinol; 2001 Nov 31; 145(5):651-8. PubMed ID: 11720885
    [Abstract] [Full Text] [Related]

  • 9. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
    Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Hölzel F, Schulz KD, Schally AV.
    Cancer Res; 1993 Nov 15; 53(22):5439-46. PubMed ID: 8221683
    [Abstract] [Full Text] [Related]

  • 10. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma.
    Irmer G, Bürger C, Müller R, Ortmann O, Peter U, Kakar SS, Neill JD, Schulz KD, Emons G.
    Cancer Res; 1995 Feb 15; 55(4):817-22. PubMed ID: 7850795
    [Abstract] [Full Text] [Related]

  • 11. Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
    Westphalen S, Kotulla G, Kaiser F, Krauss W, Werning G, Elsasser HP, Nagy A, Schulz KD, Grundker C, Schally AV, Emons G.
    Int J Oncol; 2000 Nov 15; 17(5):1063-9. PubMed ID: 11029513
    [Abstract] [Full Text] [Related]

  • 12. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C, Emons G.
    Reprod Biol Endocrinol; 2003 Oct 07; 1():65. PubMed ID: 14594454
    [Abstract] [Full Text] [Related]

  • 13. Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines.
    Emons G, Muller V, Ortmann O, Grossmann G, Trautner U, Stuckrad B, Schulz K, Schally A.
    Int J Oncol; 1996 Dec 07; 9(6):1129-37. PubMed ID: 21541621
    [Abstract] [Full Text] [Related]

  • 14. LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer.
    Emons G, Weiss S, Ortmann O, Gründker C, Schulz KD.
    Eur J Endocrinol; 2000 Jun 07; 142(6):665-70. PubMed ID: 10832105
    [Abstract] [Full Text] [Related]

  • 15. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Nagy A, Schally AV, Emons G.
    Breast Cancer Res Treat; 2004 Oct 07; 87(3):255-64. PubMed ID: 15528968
    [Abstract] [Full Text] [Related]

  • 16. Involvement of inhibitory nuclear factor-kappaB (NFkappaB)-independent NFkappaB activation in the gonadotropic regulation of X-linked inhibitor of apoptosis expression during ovarian follicular development in vitro.
    Wang Y, Chan S, Tsang BK.
    Endocrinology; 2002 Jul 07; 143(7):2732-40. PubMed ID: 12072408
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
    Stangelberger A, Schally AV, Nagy A, Szepeshazi K, Kanashiro CA, Halmos G.
    Prostate; 2006 Feb 01; 66(2):200-10. PubMed ID: 16173040
    [Abstract] [Full Text] [Related]

  • 18. Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells.
    Zhao LJ, Liu N, Li XP, Wang JL, Wei LH.
    Chin Med J (Engl); 2010 May 05; 123(9):1170-5. PubMed ID: 20529558
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells.
    Sugiyama M, Imai A, Furui T, Tamaya T.
    Oncol Rep; 2005 May 05; 13(5):813-7. PubMed ID: 15809743
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 05; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.